Tianyu Pharmaceutical Sustainability Profile
Tianyu Pharmaceutical Co., Ltd., commonly referred to as Tianyu Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in the early 2000s, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of oncology and cardiovascular health. With a strong operational presence across various regions in Asia and beyond, Tianyu Pharma is dedicated to innovation and excellence. The company’s core offerings include a diverse range of generic and proprietary medications, distinguished by their efficacy and safety profiles. Notably, Tianyu has achieved recognition for its commitment to research and development, positioning itself as a trusted name in the global pharmaceutical market.
DitchCarbon Score
How does Tianyu Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tianyu Pharmaceutical's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tianyu Pharmaceutical's reported carbon emissions
As of the latest available data, Tianyu Pharmaceutical, headquartered in China, does not report specific carbon emissions figures. However, the company is committed to climate action, having established near-term targets as part of its sustainability initiatives. These commitments are aligned with the Science Based Targets initiative (SBTi), indicating a proactive approach to reducing greenhouse gas emissions. Tianyu Pharmaceutical is classified under the chemicals sector and has made a commitment to set near-term reduction targets, although specific numerical goals have not been disclosed. The company is actively working towards integrating sustainability into its operations, reflecting a growing trend within the industry to address climate change. While no absolute emissions data is currently available, Tianyu Pharmaceutical's commitment to the SBTi demonstrates its intention to contribute to global efforts in mitigating climate impacts. The absence of emissions data may suggest that the company is in the early stages of its sustainability reporting journey or is focusing on developing its reduction strategies.
How Carbon Intensive is Tianyu Pharmaceutical's Industry?
How Carbon Intensive is Tianyu Pharmaceutical's Location?
Tianyu Pharmaceutical's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tianyu Pharmaceutical has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
